Cheng‐Ping Yu

4.7k total citations
163 papers, 3.6k citations indexed

About

Cheng‐Ping Yu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Cheng‐Ping Yu has authored 163 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 44 papers in Oncology and 41 papers in Surgery. Recurrent topics in Cheng‐Ping Yu's work include Epigenetics and DNA Methylation (9 papers), Brain Metastases and Treatment (8 papers) and Breast Cancer Treatment Studies (8 papers). Cheng‐Ping Yu is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Brain Metastases and Treatment (8 papers) and Breast Cancer Treatment Studies (8 papers). Cheng‐Ping Yu collaborates with scholars based in Taiwan, United States and China. Cheng‐Ping Yu's co-authors include Jar‐Yi Ho, Chien‐An Sun, Michael L.J. Apuzzo, Zbigniew Petrovich, Ren‐Jun Hsu, Dah‐Shyong Yü, Tang‐Yuan Chu, Jyh‐Cherng Yu, Ching Tzao and Steven L. Giannotta and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Cheng‐Ping Yu

153 papers receiving 3.5k citations

Peers

Countries citing papers authored by Cheng‐Ping Yu

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Ping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Ping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Ping Yu more than expected).

Fields of papers citing papers by Cheng‐Ping Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Ping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Ping Yu. The network helps show where Cheng‐Ping Yu may publish in the future.

Co-authorship network of co-authors of Cheng‐Ping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Ping Yu. A scholar is included among the top collaborators of Cheng‐Ping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Ping Yu. Cheng‐Ping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer 2025 ·Journal of Extracellular Vesicles ·(unknown), Dah‐Shyong Yü, Shih Sheng Jiang, (unknown), Jar‐Yi Ho, Cheng‐Ping Yu	0
2	Evaluating the antiviral efficacy and specificity of chlorogenic acid and related herbal extracts against SARS-CoV-2 variants via spike protein binding intervention 2024 ·Journal of Traditional and Complementary Medicine ·(unknown), Cheng‐Ping Yu, C. C. Chen, Chun‐Tang Chiou, Brian D. Green, Oscar K. Lee, (unknown), (unknown), Chi‐Ying F. Huang, Cheng Huang, (unknown), Yu‐Hsin Chen, Jing‐Jy Cheng, Heng‐Chih Pan, Hui‐Kang Liu	1
3	Long acting tariquidar loaded stearic acid-modified hydroxyapatite enhances brain penetration and antitumor effect of temozolomide 2024 ·European Journal of Pharmaceutics and Biopharmaceutics ·Cheng‐Ping Yu, (unknown), Jui‐Chen Tsai, (unknown)	4
4	Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer 2024 ·European Journal of Pharmacology ·(unknown), (unknown), Cheng‐Ping Yu, (unknown), (unknown), Keng‐Chang Tsai, Chen‐Hsi Chou, Chin‐Chuan Hung, Hsin‐Yi Hung	2
5	Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma 2024 ·Materials Today Bio ·(unknown), Cheng‐Ping Yu, Jui‐Chen Tsai, (unknown)	3
6	An Advanced Machine Learning Model for a Web-Based Artificial Intelligence–Based Clinical Decision Support System Application: Model Development and Validation Study 2024 ·Journal of Medical Internet Research ·(unknown), Hsing‐Yi Chung, Ming‐Jr Jian, Chih-Kai Chang, Cherng‐Lih Perng, Guo‐Shiou Liao, (unknown), (unknown), Cheng‐Ping Yu, Hung‐Sheng Shang	5
7	A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice 2023 ·Frontiers in Bioengineering and Biotechnology ·Chiyu Li, Ting Wu, (unknown), Cheng‐Ping Yu, (unknown), Xiaofang Zhou, Shanni Li, Jia‐Da Li	3
8	Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer 2022 ·Cancers ·(unknown), (unknown), Cheng‐Ping Yu, (unknown), (unknown), Jar‐Yi Ho, Dah‐Shyong Yü	17
9	Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters 2021 ·Cancers ·(unknown), Jar‐Yi Ho, Cheng‐Ping Yu, (unknown), Chia‐Lun Wu, (unknown), Hong‐Wei Gao, Dah‐Shyong Yü	16
10	Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases 2019 ·Prostate Cancer and Prostatic Diseases ·Jui‐Ming Liu, Cheng‐Ping Yu, (unknown), Chun‐Te Wu, Ren‐Jun Hsu	25
11	Increased Risk of Ulcerative Colitis in Patients with Periodontal Disease: A Nationwide Population-Based Cohort Study 2018 ·International Journal of Environmental Research and Public Health ·Chien‐Yu Lin, (unknown), Jui‐Ming Liu, (unknown), (unknown), (unknown), (unknown), Cheng‐Ping Yu, Ren‐Jun Hsu	40
12	Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf–DAPK Complex by Raf Inhibitor Combination Therapy 2015 ·Cancer Research ·(unknown), (unknown), Shou‐Hung Tang, Sheng‐Tang Wu, Yu‐Chi Chen, Guang‐Huan Sun, Pei‐Wen Hsiao, Shih‐Ming Huang, Hwei‐Jen Lee, Cheng‐Ping Yu, Jar‐Yi Ho, Hui‐Kuan Lin, (unknown), (unknown), Sun‐Yran Chang, Victor C. Lin, Dah‐Shyong Yü, Tai‐Lung Cha	18
13	A Qualitative Study Comparing the Assay Performance Characteristics Between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 Scoring Methods in Mucinous Epithelial Ovarian Cancer 2014 ·Medicine ·Chi‐Kuan Chen, Ming‐Yung Lee, Wea‐Lung Lin, Yuting Wang, Chih‐Ping Han, Cheng‐Ping Yu, Wan‐Ru Chao	5
14	Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth 2013 ·Molecular Carcinogenesis ·Tai‐Lung Cha, (unknown), Shou‐Hung Tang, Sheng‐Tang Wu, Kuang‐Hui Sun, Tzu‐Ting Chen, Guang‐Huan Sun, Sun‐Yran Chang, Cheng‐Ping Yu, Jar‐Yi Ho, (unknown), Shih‐Ming Huang, Dah‐Shyong Yü	35
15	Risk Assessment of Multistate Progression of Breast Tumor with State‐Dependent Genetic and Environmental Covariates 2013 ·Risk Analysis ·Yi‐Ying Wu, Ming‐Fang Yen, Cheng‐Ping Yu, Chien‐Jen Chen	10
16	Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation 2013 ·PLoS ONE ·Cheng‐Ping Yu, Jar‐Yi Ho, Yiting Huang, Tai‐Lung Cha, Guang‐Huan Sun, Dah‐Shyong Yü, Fung-Wei Chang, (unknown), Ren‐Jun Hsu	96
17	A spinal hamartoma in an aged woman 2011 ·The Kaohsiung Journal of Medical Sciences ·Hsin‐Chung Lin, Cheng‐Ping Yu, (unknown), Herng‐Sheng Lee	7
18	The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters 2009 ·Apmis ·(unknown), Tai‐Kuang Chao, Cheng‐Ping Yu, Mu‐Hsien Yu, (unknown)	46
19	GAMMA KNIFE RADIOSURGERY FOR BENIGN CAVERNOUS SINUS TUMORS: QUANTITATIVE ANALYSIS OF TREATMENT OUTCOMES 2004 ·Neurosurgery ·John S. Kuo, Joseph C.T. Chen, Cheng‐Ping Yu, Vladimir Zelman, Steven L. Giannotta, Zbigniew Petrovich, (unknown), Michael L.J. Apuzzo	93
20	Hypothermia and Prostaglandin E1 Produce Synergistic Attenuation of Ischemia-Reperfusion Lung Injury 1999 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), Cheng‐Ping Yu, Horng‐Chin Yan, Wann‐Cherng Perng, Chin‐Pyng Wu	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact